CHINA JO-JO DRUGSTORES, INC. - FORM 8-K - December 14, 2012
| Attached files | ||||||
| File | Filename | |||||
|---|---|---|---|---|---|---|
| EX-99.1 - CHINA JO-JO DRUGSTORES, INC. | ex99.htm | |||||
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
|
Date of report (Date of earliest event reported):
|
December 14, 2012
|
|
CHINA JO-JO DRUGSTORES, INC.
|
|
(Exact name of registrant as specified in its charter)
|
|
Nevada
|
001-34711
|
98-0557852
|
||
|
(State or other jurisdiction
of incorporation)
|
(Commission File No.)
|
(IRS Employer
Identification No.)
|
|
Room 507-513, 5th Floor, A Building, Meidu Plaza
Gongshu District, Hangzhou, Zhejiang Province
People’s Republic of China
|
||
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code
|
+86 (571) 88077078
|
|
N/A
|
|
(Former name or former address, if changed since last report)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Item 8.01 Other Events.
On December 14, 2012, the registrant received a letter from The NASDAQ Stock Market LLC (“NASDAQ”) notifying the registrant that it had regained compliance with NASDAQ Listing Rule 5550(a)(2), as the closing bid price of the Company’s common stock had been at or above $1.00 per share for at least 10 consecutive trading days. The letter further stated that this matter, which had been previously communicated to the Company in NASDAQ’s noncompliance notice dated August 31, 2012 (and which the registrant disclosed in its Current Report on Form 8-K filed with the Securities and Exchange Commission on September 6, 2012), is now closed.
On December 14, 2012, the registrant issued a press release announcing its receipt of the letter. A copy of the press release is attached hereto as Exhibit 99.1.
| Item 9.01 Financial Statement and Exhibits. |
| (d) EXHIBITS |
|
Exhibit Number
|
Description
|
|
|
99.1
|
Press release dated December 14, 2012.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
CHINA JO-JO DRUGSTORES, INC.
|
||||
|
Date:
|
December 14, 2012
|
(Registrant)
|
||
|
By:
|
/s/ Ming Zhao
|
|||
|
Ming Zhao
|
||||
|
Chief Financial Officer
|
||||
User Contributions:
Comment about this document or add new information about this topic:
This web site and associated pages are not associated with, endorsed by, or sponsored by CHINA JO-JO DRUGSTORES, INC. and has no official or unofficial affiliation with CHINA JO-JO DRUGSTORES, INC.
Based on public records. Inadvertent errors are possible.
Faqs.org does not guarantee the accuracy or timeliness of any information on this site. Use at your own risk.
This website is not associated with the SEC
Some parts © 2013 Advameg, Inc.
